ISIS: Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease

New alert via PocketInfo for ISIS:

Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease

Press Releases: http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-news&nyo=0
SEC Filings: http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-sec
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8